During his talk titled "From University Collaboration to $100M Acquisition: A Tearful Tale of BioDesign," Ackermann will explain how acquisition by a global pharmaceutical giant is helping him achieve his goal of reaching as many patients as possible and will highlight his journey as a BioDesign Fellow at the Stanford Byers Center for BioDesign. Ackermann will discuss why big tech companies have yet to disrupt healthcare and how that translates into big opportunities for entrepreneurs, students, and faculty interested in startups.
The seminar is scheduled for Thursday, Oct. 26 from 6:00- 7:15 p.m. in Fung Auditorium in the Powell-Focht Bioengineering Hall. Register to attend at http://bluelincsd.com/.
No comments:
Post a Comment